Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1633
This examiner grants 76% of resolved cases
Qinhua Gu is an examiner in Tech Center 1600 and Art Unit 1633. Across 83 resolved cases, the data shows an allowance rate of 75.9 percent. This 75.9 percent figure provides a baseline for practitioners to understand the probability of a grant. The 83 resolved cases offer a look at the examiner's historical tendencies in this biotechnology and organic chemistry center.
The data reveals an interview lift of 27.8 percent. This 27.8 percent lift indicates that an interview is associated with a higher likelihood of allowance compared to the baseline of cases where no interview is conducted. Practitioners may use this metric to evaluate the impact of verbal advocacy. This comparison is a key element of the prosecution strategy for cases in Art Unit 1633.
The median days to allowance for Gu is 1398. This 1398-day period serves as a benchmark for the expected duration of successful prosecutions. The combination of the 75.9 percent allowance rate and the 27.8 percent interview lift, within the context of Tech Center 1600, helps in setting expectations for both timing and results.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18285000 | MODIFIED VIRUSES AND VIRAL PARTICLES, METHODS OF MAKING, AND USES THEREOF | Final Rejection | The Regents of the University of California |
| 18921141 | METHODS TO IMPROVE SITE-DIRECTED INTEGRATION FREQUENCY | Non-Final OA | Monsanto Technology LLC |
| 17995263 | HIGH-POTENTIAL PLURIPOTENT STEM CELLS | Non-Final OA | TOHOKU UNIVERSITY |
| 18705720 | CONTROLLING HOMEOSTATIC REGULATORY CIRCUITRY IN HYPOTHALAMUS | Non-Final OA | The Johns Hopkins University |
| 18551562 | RECOMBINANT VIRAL EXPRESSION VECTORS AND METHODS OF USE | Non-Final OA | North Carolina State University |
| 17997264 | Precision Dosing Regimen | Non-Final OA | CHILDREN'S HOSPITAL MEDICAL CENTER |
| 18704122 | CULTURE MEDIA AND CONDITIONS FOR IN VITRO EXPANSION AND/OR MATURATION OF HEPATOCYTES | Non-Final OA | Satellite Biosciences, Inc. |
| 17778463 | VACCINIA VIRUSES AND METHODS FOR USING VACCINIA VIRUSES | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18279336 | STROMA-FREE NK CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | Non-Final OA | The Children's Medical Center Corporation |
| 17907571 | MAINTAINING DNA FRAGMENTS IN EUKARYOTIC CELLS, APPROACHES AND USES | Final Rejection | Greffex, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy